Tag: upcoming
ObsEva Conference Call and Webcast 6th January
ObsEva Announces Symposium and Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at SEUD Congress 2021
ObsEva Announces Presentation of Clinical Data on Oral GnRH Antagonist Linzagolix at ASRM 2021 Scientific Congress & Expo
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
ObsEva to Present at Upcoming Investor Conferences
ObsEva to Present Ebopiprant (OBE022) Data at the Society for Reproductive Investigation 68th Annual Meeting
ObsEva To Present Data on Two Clinical Development Programs at ESHRE Virtual 37th Annual Meeting
ObsEva to Present Oral Presentation at the RCOG Virtual World Congress 2021
Title: A Randomised, Placebo-Controlled, Proof-of-Concept Trial of Ebopiprant for Spontaneous Preterm Labor (PROLONG) Abstract ID: 601 Presenter: Ben Mol, Ph.D.,…
Save the date: ObsEva Annual General Meeting May 28, 2021
May 28, 2021 at 16:30 CEST At the company’s offices in Geneva, Chemin des Aulx 12, 3rd floor, 1228 Plan-les-Ouates, Switzerland. Click here…